Product Information
MEPROBAMATE 400 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $6.0362 per EA under NDC 69097097507. Its NADAC has been published 167 times since Apr 20, 2022.
Strength
400 mg/1
Manufacturer
Cipla USA Inc.NDC
69097097507
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEPROBAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA040797On Market Since
6/7/2021
Price Statistics
The NADAC for MEPROBAMATE 400 MG TABLET has been published 167 times since Apr 20, 2022, and over the history we have for it it has risen 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0362 per EA |
|---|---|
| All-time high | $6.0533 (Dec 10, 2025) |
| All-time low | $4.9689 (Aug 21, 2024) |
| 52-week high | $6.0533 |
| 52-week low | $5.6163 |
| Median price | $5.5728 |
| Average price | $5.4472 |
| Largest weekly change | +14.6% (Oct 23, 2024) |
| Weeks tracked | 167 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEPROBAMATE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEPROBAMATE 400 MG TABLET, manufactured by Cipla USA Inc., is $6.0362 per EA (NDC 69097097507), effective Jun 24, 2026.
How has the price of MEPROBAMATE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEPROBAMATE 400 MG TABLET has risen 18.9%. It has been tracked across 167 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for MEPROBAMATE 400 MG TABLET?
Since Apr 20, 2022, the NADAC for MEPROBAMATE 400 MG TABLET has ranged from a low of $4.9689 (Aug 21, 2024) to a high of $6.0533 (Dec 10, 2025), with a median of $5.5728 per EA.
Are there cheaper alternatives to MEPROBAMATE 400 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MEPROBAMATE 400 MG TABLET, but none are currently priced below it.
Who manufactures MEPROBAMATE 400 MG TABLET?
MEPROBAMATE 400 MG TABLET (NDC 69097097507) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification